Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 272

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 272
---
) 50% upon the completion of a financing transaction generating at least $1.5 million of gross proceeds,
in each case subject to such director’s continued service.

Messrs. Atwood and Ehrlich
and Dr. Corey each served as executive officers and directors during portions of 2024. Each of Mr. Atwood’s, Mr. Ehrlich’s
and Dr. Corey’s compensation is summarized above in “Executive Compensation—Employment Agreements.”

Director Compensation Table

The following table sets
forth information regarding the compensation awarded to, earned by or paid to our non-employee directors for service on our board of
directors during the year ended December 31, 2024.

| Name                |     | Fees Earned 
 or Paid in  
 Cash ($)    |        |    |     | Option         
 Awards (number 
 of shares)     |       |    |     | All Other    
 Compensation 
 ($)          |         |    |     | Total 
 ($)   |         |    |
|:--------------------|:----|:------------|-------:|---:|:----|:---------------|------:|---:|:----|:-------------|--------:|---:|:----|:------|--------:|---:|
| Michael Byrnes      |     | $           | 26,250 |    |     |                | 3,675 | -1 |     |              |       - |    |     | $     |  26,250 |    |
| Kathleen LaPorte    |     | $           | 26,250 |    |     |                | 3,675 | -1 |     |              |       - |    |     | $     |  26,250 |    |
| Lindsey Rolfe, M.D. |     | $           | 26,250 |    |     |                | 3,675 | -1 |     |              |       - |    |     | $     |  26,250 |    |
| Shami Patel         |     | $           |  7,500 |    |     |                | 2,550 | -2 |     |              | 105,000 | -2 |     | $     | 115,050 |    |
| Robyn Rapaport      |     | $           | 18,750 | -4 |     |                | 1,125 | -3 |     |